Antibiotics do not reduce post-tonsillectomy morbidity in children

Abdulmonem Al-Layla1, Tareq M Mahafza

  • 1ENT Department, Jordan University Hospital, Faculty of Medicine, University of Jordan, PO Box 13046, Amman, Jordan.

Insights

Antibiotic use after tonsillectomy in children did not reduce complications like fever or pain. Routine antibiotic prescription is not recommended; consider it only on a case-by-case basis for post-tonsillectomy care.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Infectious Diseases

Background:

  • Post-tonsillectomy morbidity, including fever, pain, and bleeding, can impact pediatric recovery.
  • The routine use of antibiotics to mitigate these complications is a common practice but lacks robust evidence.

Purpose of the Study:

  • To evaluate the effectiveness of antibiotic administration in reducing common morbidities following tonsillectomy in children.

Main Methods:

  • A randomized clinical trial was conducted with pediatric patients undergoing tonsillectomy.
  • Patients were divided into two groups: one received amoxicillin with clavulanic acid post-operatively, while the control group received no antibiotics.
  • Outcomes measured included fever, secondary bleeding, throat pain duration, and time to resume a normal diet.

Main Results:

  • Secondary bleeding occurred more frequently in the antibiotic group (5.5%) compared to the no-antibiotic group (2%).
  • Average throat pain duration and time to resume a normal diet were slightly longer in the antibiotic group.
  • Fever rates were similar between the two groups (31% vs. 30%).

Conclusions:

  • Post-tonsillectomy antibiotic use does not appear to decrease post-operative morbidity in children.
  • Routine antibiotic prescription following tonsillectomy is not supported; individualized assessment is advised.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...